Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

BACKGROUND: During stavudine phase-out plan in developing countries, tenofovir is used to substitute stavudine. However, knowledge regarding whether there is any difference of the frequency of renal injury between tenofovir/lamivudine/efavirenz and tenofovir/lamivudine/nevirapine is lacking. METHODS...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Manosuthi, Weerawat, Mankatitham, Wiroj, Lueangniyomkul, Aroon, Prasithsirikul, Wisit, Tantanathip, Preecha, Suntisuklappon, Busakorn, Narkksoksung, Anongnuch, Nilkamhang, Samruay, Sungkanuparph, Somnuek
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2010
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3020664/
https://ncbi.nlm.nih.gov/pubmed/20937122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-7-37
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge